User profiles for Bin Ju

Bin Ju

南方科技大学副研究员
Verified email at mail.sustech.edu.cn
Cited by 2327

[HTML][HTML] Human neutralizing antibodies elicited by SARS-CoV-2 infection

B Ju, Q Zhang, J Ge, R Wang, J Sun, X Ge, J Yu… - Nature, 2020 - nature.com
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) presents a global health emergency that is in urgent …

[HTML][HTML] Clinical outcome of direct pulp capping with MTA or calcium hydroxide: a systematic review and meta-analysis

C Zhu, B Ju, R Ni - … journal of clinical and experimental medicine, 2015 - ncbi.nlm.nih.gov
Direct pulp capping is one of the most common dental practices in endodontic therapy. This
systematic review and meta-analysis aim to determine whether the effect of mineral trioxide …

[PDF][PDF] Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species

R Wang, Q Zhang, J Ge, W Ren, R Zhang, J Lan, B Ju… - Immunity, 2021 - cell.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to emerge
during the global pandemic and may facilitate escape from current antibody therapies and …

[PDF][PDF] The architecture of inactivated SARS-CoV-2 with postfusion spikes revealed by cryo-EM and cryo-ET

…, L Mendonça, Y Yang, Y Gao, C Shen, J Liu, T Ni, B Ju… - Structure, 2020 - cell.com
The ongoing global pandemic of coronavirus disease 2019 (COVID-19) resulted from the
outbreak of SARS-CoV-2 in December 2019. Currently, multiple efforts are being made to …

[HTML][HTML] Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants

B Ju, Q Zhang, Z Wang, ZQ Aw, P Chen, B Zhou… - Nature …, 2023 - nature.com
The omicron variants of SARS-CoV-2 have substantial ability to escape infection- and
vaccine-elicited antibody immunity. Here, we investigated the extent of such escape in nine …

[HTML][HTML] Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2

Q Zhang, B Ju, J Ge, JFW Chan, L Cheng… - Nature …, 2021 - nature.com
Neutralizing antibodies (nAbs) to SARS-CoV-2 hold powerful potentials for clinical
interventions against COVID-19 disease. However, their common genetic and biologic features …

[HTML][HTML] Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry

J Ge, R Wang, B Ju, Q Zhang, J Sun, P Chen… - Nature …, 2021 - nature.com
Understanding the mechanism for antibody neutralization of SARS-CoV-2 is critical for the
development of effective therapeutics and vaccines. We recently isolated a large number of …

[HTML][HTML] Risk factors analysis of COVID-19 patients with ARDS and prediction based on machine learning

W Xu, NN Sun, HN Gao, ZY Chen, Y Yang, B Ju… - Scientific reports, 2021 - nature.com
COVID-19 is a newly emerging infectious disease, which is generally susceptible to human
beings and has caused huge losses to people's health. Acute respiratory distress syndrome (…

[HTML][HTML] Antigenic sin of wild-type SARS-CoV-2 vaccine shapes poor cross-neutralization of BA. 4/5/2.75 subvariants in BA. 2 breakthrough infections

B Ju, Q Fan, M Wang, X Liao, H Guo, H Wang… - Nature …, 2022 - nature.com
With declining SARS-CoV-2-specific antibody titers and increasing numbers of spike mutations,
the ongoing emergence of Omicron subvariants causes serious challenges to current …

[PDF][PDF] Key gp120 glycans pose roadblocks to the rapid development of VRC01-class antibodies in an HIV-1-infected Chinese donor

L Kong, B Ju, Y Chen, L He, L Ren, J Liu, K Hong, B Su… - Immunity, 2016 - cell.com
VRC01-class antibodies neutralize diverse HIV-1 strains by targeting the conserved CD4-binding
site. Despite extensive investigations, crucial events in the early stage of VRC01 …